BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 28837146)

  • 1. Adropin deficiency worsens HFD-induced metabolic defects.
    Chen S; Zeng K; Liu QC; Guo Z; Zhang S; Chen XR; Lin JH; Wen JP; Zhao CF; Lin XH; Gao F
    Cell Death Dis; 2017 Aug; 8(8):e3008. PubMed ID: 28837146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enho Mutations Causing Low Adropin: A Possible Pathomechanism of MPO-ANCA Associated Lung Injury.
    Gao F; Fang J; Chen F; Wang C; Chen S; Zhang S; Lv X; Zhang J; He Q; Weng S; Liu Q; Lin XH
    EBioMedicine; 2016 Jul; 9():324-335. PubMed ID: 27333037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum adropin levels are decreased in Chinese type 2 diabetic patients and negatively correlated with body mass index.
    Zang H; Jiang F; Cheng X; Xu H; Hu X
    Endocr J; 2018 Jul; 65(7):685-691. PubMed ID: 29669965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adropin deficiency is associated with increased adiposity and insulin resistance.
    Ganesh Kumar K; Zhang J; Gao S; Rossi J; McGuinness OP; Halem HH; Culler MD; Mynatt RL; Butler AA
    Obesity (Silver Spring); 2012 Jul; 20(7):1394-402. PubMed ID: 22318315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of adropin as a secreted factor linking dietary macronutrient intake with energy homeostasis and lipid metabolism.
    Kumar KG; Trevaskis JL; Lam DD; Sutton GM; Koza RA; Chouljenko VN; Kousoulas KG; Rogers PM; Kesterson RA; Thearle M; Ferrante AW; Mynatt RL; Burris TP; Dong JZ; Halem HA; Culler MD; Heisler LK; Stephens JM; Butler AA
    Cell Metab; 2008 Dec; 8(6):468-81. PubMed ID: 19041763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adropin's Role in Energy Homeostasis and Metabolic Disorders.
    Ali II; D'Souza C; Singh J; Adeghate E
    Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Serum Adropin Concentrations with Diabetic Nephropathy.
    Hu W; Chen L
    Mediators Inflamm; 2016; 2016():6038261. PubMed ID: 27546995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of adropin in arterial stiffening associated with obesity and type 2 diabetes.
    Jurrissen TJ; Ramirez-Perez FI; Cabral-Amador FJ; Soares RN; Pettit-Mee RJ; Betancourt-Cortes EE; McMillan NJ; Sharma N; Rocha HNM; Fujie S; Morales-Quinones M; Lazo-Fernandez Y; Butler AA; Banerjee S; Sacks HS; Ibdah JA; Parks EJ; Rector RS; Manrique-Acevedo C; Martinez-Lemus LA; Padilla J
    Am J Physiol Heart Circ Physiol; 2022 Nov; 323(5):H879-H891. PubMed ID: 36083795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic adropin is regulated by estrogen and contributes to adverse metabolic phenotypes in ovariectomized mice.
    Stokar J; Gurt I; Cohen-Kfir E; Yakubovsky O; Hallak N; Benyamini H; Lishinsky N; Offir N; Tam J; Dresner-Pollak R
    Mol Metab; 2022 Jun; 60():101482. PubMed ID: 35364299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adropin reduces blood glucose levels in mice by limiting hepatic glucose production.
    Thapa D; Xie B; Manning JR; Zhang M; Stoner MW; Huckestein BR; Edmunds LR; Zhang X; Dedousis NL; O'Doherty RM; Jurczak MJ; Scott I
    Physiol Rep; 2019 Apr; 7(8):e14043. PubMed ID: 31004398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antidiabetic and hypolipidemic effects of adropinin streoptozotocin-induced type 2 diabetic rats.
    Akcilar R; Kocak FE; Simsek H; Akcilar A; Bayat Z; Ece E; Kokdasgil H
    Bratisl Lek Listy; 2016; 117(2):100-5. PubMed ID: 26830041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of adropin on proliferation and differentiation of 3T3-L1 cells and rat primary preadipocytes.
    Jasaszwili M; Wojciechowicz T; Billert M; Strowski MZ; Nowak KW; Skrzypski M
    Mol Cell Endocrinol; 2019 Oct; 496():110532. PubMed ID: 31400396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum Adropin as a Potential Biomarker for Predicting the Development of Type 2 Diabetes Mellitus in Individuals With Metabolic Dysfunction-Associated Fatty Liver Disease.
    Li N; Xie G; Zhou B; Qu A; Meng H; Liu J; Wang G
    Front Physiol; 2021; 12():696163. PubMed ID: 34366886
    [No Abstract]   [Full Text] [Related]  

  • 14. Adropin deficiency worsens TNBS-induced colitis.
    Liu Q; Zhang S; Liu G; Zhou H; Guo Y; Gao F; Weng S
    Int Immunopharmacol; 2023 Nov; 124(Pt A):110891. PubMed ID: 37688913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low plasma adropin concentrations increase risks of weight gain and metabolic dysregulation in response to a high-sugar diet in male nonhuman primates.
    Butler AA; Zhang J; Price CA; Stevens JR; Graham JL; Stanhope KL; King S; Krauss RM; Bremer AA; Havel PJ
    J Biol Chem; 2019 Jun; 294(25):9706-9719. PubMed ID: 30988006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adropin regulates hepatic glucose production via PP2A/AMPK pathway in insulin-resistant hepatocytes.
    Chen X; Chen S; Shen T; Yang W; Chen Q; Zhang P; You Y; Sun X; Xu H; Tang Y; Mi J; Yang Y; Ling W
    FASEB J; 2020 Aug; 34(8):10056-10072. PubMed ID: 32579277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adropin: An endocrine link between the biological clock and cholesterol homeostasis.
    Ghoshal S; Stevens JR; Billon C; Girardet C; Sitaula S; Leon AS; Rao DC; Skinner JS; Rankinen T; Bouchard C; Nuñez MV; Stanhope KL; Howatt DA; Daugherty A; Zhang J; Schuelke M; Weiss EP; Coffey AR; Bennett BJ; Sethupathy P; Burris TP; Havel PJ; Butler AA
    Mol Metab; 2018 Feb; 8():51-64. PubMed ID: 29331507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal changes in serum adropin levels and liver fat content during liraglutide treatment in newly diagnosed patients with type 2 diabetes mellitus and metabolic dysfunction-associated fatty liver disease.
    Zhang L; Wu X; Li X; Chang X; Ding X; Wang Q; Jiang T; Wang G; Liu J
    Acta Diabetol; 2023 Jul; 60(7):971-979. PubMed ID: 37079136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exercise suppresses NLRP3 inflammasome activation in mice with diet-induced NASH: a plausible role of adropin.
    Yang W; Liu L; Wei Y; Fang C; Liu S; Zhou F; Li Y; Zhao G; Guo Z; Luo Y; Li L
    Lab Invest; 2021 Mar; 101(3):369-380. PubMed ID: 33268842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum adropin level and ENHO gene expression in systemic sclerosis.
    Yolbas S; Kara M; Yilmaz M; Aydin S; Koca SS
    Clin Rheumatol; 2016 Jun; 35(6):1535-40. PubMed ID: 27079850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.